Cancer survival: global surveillance will stimulate health policy and improve equity

Global cancer statistics

Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291

Global cancer transitions according to the Human Development Index (2008–2030): a population-based study

Bray, F., Jemal, A., Grey, N., Ferlay, J., & Forman, D. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70211-5 · Cited by 2,225

Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data

Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. H. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70246-2 · Cited by 1,285

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

Coleman, M. P., Forman, D., Bryant, H., Butler, J., Rachet, B., Maringe, C., Nur, U., Tracey, E. A., Coory, M. D., Hatcher, J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62231-3 · Cited by 1,114

Origins of socio-economic inequalities in cancer survival: a review

Woods, L. M., Rachet, B., & Coleman, M. P. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj007 · Cited by 1,101

EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary

Sant, M., Allemani, C., Santaquilani, M., Knijn, A., Marchesi, F., & Capocaccia, R. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.018 · Cited by 1,020

EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary

Sant, M., Aareleid, T., Berrino, F., Lasota, M. B., Carli, P., Faivre, J., Grosclaude, P., Hédelin, G., Matsuda, T., Møller, H., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg754 · Cited by 1,010

Cancer survival in five continents: a worldwide population-based study (CONCORD)

Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70179-7 · Cited by 1,002

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

Fitzmaurice, C., Allen, C., Barber, R. M., Barregård, L., Bhutta, Z. A., Brenner, H., Dicker, D., Chimed‐Ochir, O., Dandona, R., Dandona, L., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,318

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145

Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614

Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries

Zeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J. S., Zou, X., Xia, C., Sun, K., Yang, Z., Li, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30127-x · Cited by 1,558

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.10.023 · Cited by 1,031

40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study

Quaresma, M., Coleman, M. P., & Rachet, B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61396-9 · Cited by 458

Cancer Survivors’ Experience With Telehealth: A Systematic Review and Thematic Synthesis.

Cox, A., Lucas, G., Marcu, A., Piano, M., Grosvenor, W., Mold, F., Maguire, R., & Ream, E. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.6575 · Cited by 330

Health at a Glance: Latin America and the Caribbean 2020

OECD, & Bank, T. W. (2020) · OECD eBooks · doi:10.1787/6089164f-en · Cited by 334

Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines

Alexandre, J., Cautela, J., Éderhy, S., Damaj, G. L., Salem, J., Barlési, F., Farnault, L., Charbonnier, A., Mirabel, M., Champiat, S., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018403 · Cited by 303

Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality

Pávó, N., Raderer, M., Hülsmann, M., Neuhold, S., Adlbrecht, C., Strunk, G., Goliasch, G., Gisslinger, H., Steger, G. G., Hejna, M., et al. (2015) · Heart · doi:10.1136/heartjnl-2015-307848 · Cited by 272

Rethinking the war on cancer

Hanahan, D. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62226-6 · Cited by 271

Global cancer statistics for adolescents and young adults: population based study

Li, W., Liang, H., Wang, W., Liu, J., Liu, X., Lao, S., Liang, W., & He, J. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01623-9 · Cited by 190

An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries

Wells, J. C., Sharma, S. M., Paggio, J. C. D., Hopman, W. M., Gyawali, B., Mukherji, D., Hammad, N., Pramesh, C. S., Aggarwal, A. K., Sullivan, R. J., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.7478 · Cited by 177

CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer

Wang, W., Yuan, X.-L., Chen, H., Xie, G.-H., Ma, Y., Zheng, Y., Zhou, Y., & Shen, L.-S. (2015) · Oncotarget · doi:10.18632/oncotarget.5588 · Cited by 154

Global efforts toward the cure of childhood acute lymphoblastic leukaemia

Pui, C., Yang, J. J. J., Bhakta, N. H., & Galindo, C. R. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30066-x · Cited by 136

Worldwide cancer statistics of adolescents and young adults in 2019: a systematic analysis of the Global Burden of Disease Study 2019

You, L., Lv, Z., Li, C., Ye, W., Zhou, Y., Jin, J., & Han, Q. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100255 · Cited by 115

Essential TNM: a registry tool to reduce gaps in cancer staging information

Piñeros, M., Parkin, D. M., Ward, K. C., Chokunonga, E., Ervik, M., Farrugia, H., Gospodarowicz, M. K., O’Sullivan, B., Soerjomataram, I., Swaminathan, R., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30897-0 · Cited by 113

European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

Lawler, M., Davies, L., Oberst, S., Oliver, K. R., Eggermont, A. M. M., Schmutz, A., Vecchia, C. L., Allemani, C., Lievens, Y. N., Naredi, P. L. J., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00540-x · Cited by 116

Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis

Eloranta, S., Smedby, K. E. E., Dickman, P. W., & Andersson, T. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13139 · Cited by 110

Glioblastoma Survival is Improving Despite Increasing Incidence Rates: A Nationwide Study between 2000 and 2013 in Finland

Korja, M., Raj, R., Seppä, K., Luostarinen, T., Malila, N. K., Seppälä, M., Mäenpää, H. O., & Pitkäniemi, J. M. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy164 · Cited by 104

Predictors of cervical cancer screening among Kenyan women: results of a nested case-control study in a nationally representative survey

Ng’ang’a, A., Nyangasi, M. F., Nkonge, N. G., Gathitu, E., Kibachio, J. M., Gichangi, P., Wamai, R. G., & Kyobutungi, C. K. (2018) · BMC Public Health · doi:10.1186/s12889-018-6054-9 · Cited by 105

Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and Outcomes

Shulman, L. N., Wagner, C. M., Barr, R. D., Lopes, G. D. L., Jr., Longo, G., Robertson, J., Forte, G. B., Torode, J., & Magrini, N. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.8736 · Cited by 98

A nanoplasmonic biosensor for label-free multiplex detection of cancer biomarkers

Lee, J. U., Anh, N. T. V., & Sim, S. J. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.06.059 · Cited by 95

CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma

Zhang, C. Z., Chen, S.-L., Wang, C., He, Y.-F., Yang, X., Xie, D., & Yun, J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0700 · Cited by 91

Cancer care in Brazil: structure and geographical distribution

da Silva, M. J. S., O’Dwyer, G., & Osorio-de-Castro, C. G. S. (2019) · BMC Cancer · doi:10.1186/s12885-019-6190-3 · Cited by 86

Disparities in breast cancer survival in the United States (2001‐2009): Findings from the CONCORD‐2 study

Miller, J. W., Smith, J. L., Ryerson, A. B., Tucker, T. C., & Allemani, C. (2017) · Cancer · doi:10.1002/cncr.30988 · Cited by 83

Global, Regional, and National Burden of Chronic Myeloid Leukemia, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017

Lin, Q., Mao, L., Shao, L. H., Zhu, L., Han, Q., Zhu, H., Jin, J., & You, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.580759 · Cited by 78

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries

Ssenyonga, N., Stiller, C. A., Nakata, K., Shalkow‐Klincovstein, J., Redmond, S. M., Bulliard, J., Girardi, F., Fowler, C. E., Marcos‐Gragera, R., Bonaventure, A., et al. (2022) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(22)00095-5 · Cited by 76

Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)

Girardi, F., Matz, M., Stiller, C. A., You, H., Gragera, R. M., Valkov, М. Y., Bulliard, J., De, P., Morrison, D. S., Wanner, M., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac217 · Cited by 78

Worldwide Trends in Survival From Common Childhood Brain Tumors: A Systematic Review

Girardi, F., Allemani, C., & Coleman, M. P. (2019) · Journal of Global Oncology · doi:10.1200/jgo.19.00140 · Cited by 73

FOXK2, regulted by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma

Lin, M., Yang, Y.-F., Peng, Z., Zhang, M., Liang, J., Chen, W., Liu, X., & Zheng, Y. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.05.019 · Cited by 72

TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma

Yang, Y.-F., Zhang, M., Tian, Q., & Zhang, C. Z. (2017) · Journal of Cell Science · doi:10.1242/jcs.206623 · Cited by 72

Panorama de la Salud: Latinoamérica y el Caribe 2020

OECD, & Bank, T. W. (2020) · OECD eBooks · doi:10.1787/740f9640-es · Cited by 106

Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England

Syriopoulou, E., Bower, H., Andersson, T., Lambert, P. C., & Rutherford, M. J. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.300 · Cited by 65

Incidence, mortality, survival, and treatment statistics of cancers in digestive organs—Japanese cancer statistics 2024

Higashi, T., & Kurokawa, Y. (2024) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12835 · Cited by 58

MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma

Bi, J., Zheng, J.-F., Li, Q., Bao, S., Yu, X., Xu, P., & Liao, C.-X. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.11.011 · Cited by 59

miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma

Xu, X., Tao, Y., Niu, Y., Wang, Z., Zhang, C., Yu, Y., & Ma, L. (2019) · Aging · doi:10.18632/aging.102276 · Cited by 53

Sociodemographic Factors and Stage of Cancer at Diagnosis: A Population-Based Study in South India

Mathew, A., George, P. S., Ramadas, K., Mathew, B. S., Kumar, A. A., Roshni, S., Jayakumar, K. N. L., & Booth, C. M. (2019) · Journal of Global Oncology · doi:10.1200/jgo.18.00160 · Cited by 51

CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells

Huang, X., Xiang, L., Wang, B., Hu, J., Liu, C., Ren, A., Du, K., Ye, G., Liang, Y., Tang, Y., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02787-5 · Cited by 50

Ailanthone: A novel potential drug for treating human cancer (Review)

Ding, H., Yu, X., Chen, H., Gao, K., Lao, X., Jia, Y., & Yan, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.11710 · Cited by 48

The role and utility of population-based cancer registries in cervical cancer surveillance and control

Piñeros, M., Saraiya, M., Baussano, I., Bonjour, M., Chao, A., & Bray, F. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106237 · Cited by 49

FAM 134B induces tumorigenesis and epithelial‐to‐mesenchymal transition via Akt signaling in hepatocellular carcinoma

Zhang, Z., Chen, J., Huang, W., Deng, N., Liu, Q., Wang, C., Zhang, L., Ren, L., Chu, L., Liang, H., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12429 · Cited by 46

Drug Development in Low- and Middle-Income Countries: Opportunity or Exploitation?

Jalali, R., Nogueira‐Rodrigues, A., Das, A., Sirohi, B., & Panda, P. K. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_10033 · Cited by 45

Adult leukemia survival trends in the United States by subtype: A population‐based registry study of 370,994 patients diagnosed during 1995‐2009

Bailey, C., Richardson, L. C., Allemani, C., Bonaventure, A., Harewood, R., Moore, A. R., Stewart, S. L., Weir, H. K., Coleman, M. P., & CONCORD Working Group (US members) (2018) · Cancer · doi:10.1002/cncr.31674 · Cited by 43

Mobile health for cancer in low to middle income countries: priorities for research and development: mHealth for cancer in low income countries

Holeman, I., Evans, J., Kane, D., Grant, L., Pagliari, C., & Weller, D. (2014) · European Journal of Cancer Care · doi:10.1111/ecc.12250 · Cited by 42

Incidence of surgery for chronic subdural hematoma in Finland during 1997–2014: a nationwide study

Tommiska, P., Luostarinen, T., Kaprio, J. A., Korja, M., Lönnrot, K., Kivisaari, R., & Raj, R. (2021) · Journal of neurosurgery · doi:10.3171/2021.3.jns21281 · Cited by 40

Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition

Zhou, Y., Xue, R., Wang, J., & Ren, H. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20198882 · Cited by 38

Pharmacogenomics and targeted therapy of cancer: Focusing on non-small cell lung cancer

Haghgoo, S. M., Allameh, A., Mortaz, E., Garssen, J., Folkerts, G., Barnes, P. J., & Adcock, I. M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.029 · Cited by 39

Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000–2014 (CONCORD-3)

Girardi, F., Carlo, V. D., Stiller, C. A., Gatta, G., Woods, R. R., Visser, O. J., Lacour, B., Tucker, T. C., Coleman, M. P., Allemani, C., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac232 · Cited by 37

Population‐based cancer survival in the United States: Data, quality control, and statistical methods

Allemani, C., Harewood, R., Johnson, C. J., Carreira, H., Spika, D., Bonaventure, A., Ward, K., Weir, H. K., & Coleman, M. P. (2017) · Cancer · doi:10.1002/cncr.31025 · Cited by 35

Global Pattern of Nasopharyngeal Cancer: Correlation of Outcome With Access to Radiation Therapy

Lam, K. O., Lee, A. W. M., Choi, C., Sze, H. C., Zietman, A. L., Hopkins, K. I., & Rosenblatt, E. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.11.047 · Cited by 33

Medication Reconciliation in Oncological Patients: A Randomized Clinical Trial

Vega, T. G.-C., Sierra-Sánchez, J. F., Bautista, M. J. M., García-Martín, F., Suárez-Carrascosa, F., & Baena-Cañada, J. M. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.15248 · Cited by 31

Public health surveillance of cancer survival in the United States and worldwide: The contribution of the CONCORD programme

Allemani, C., & Coleman, M. P. (2017) · Cancer · doi:10.1002/cncr.30854 · Cited by 28

THE POPULATION-BASED CANCER REGISTRY AS A RESOURCE FOR RESEARCH AND PRACTICAL HEALTHCARE

Valkov, М. Y., Карпунов, А. А., Coleman, M. P., Allemani, C., Pankratieva, A. Y., Потехина, Е. Ф., Евгеньевна, В. Л., & Grjibovski, A. M. (2017) · Экология человека · doi:10.33396/1728-0869-2017-5-54-62 · Cited by 28

Distribution of cervical and breast cancer risk factors in women and their screening behaviours

Arlı, Ş. K., Bakan, A. B., & Aslan, G. (2018) · European Journal of Cancer Care · doi:10.1111/ecc.12960 · Cited by 27

ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023

Čufer, T., Kosty, M. P., & on behalf of the Curriculum Development Subgroup—ESMO/ASCO Global Curriculum Working Group (2023) · JCO Global Oncology · doi:10.1200/go.23.00277 · Cited by 26

CEP131 indicates poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma

Liu, X., Yang, Y.-F., Fang, H.-Y., Wang, X., Zhang, M., & Wu, D.-C. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.07.001 · Cited by 24

Affordable Care Act and Disparities in Health Services Utilization among Ethnic Minority Breast Cancer Survivors: Evidence from Longitudinal Medical Expenditure Panel Surveys 2008–2015

White‐Means, S. I., & Osmani, A. R. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15091860 · Cited by 24

High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis

Yang, X., Zang, H., Luo, Y., Wu, J., Fang, Z., Zhu, W., & Li, Y. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s148662 · Cited by 23

Population‐based cancer survival (2001 to 2009) in the United States: Findings from the CONCORD‐2 study

Weir, H. K., Stewart, S. L., Allemani, C., White, M. C., Thomas, C. C., White, A., Coleman, M. P., & for the CONCORD Working Group (US Members) (2017) · Cancer · doi:10.1002/cncr.31028 · Cited by 21

Geographic Disparities in Oral Cancer Survival From 10 Population-Based Cancer Registries in India

Sathishkumar, K., Sankarapillai, J., Santhappan, S., Mathew, A., Nair, R. A., Gangane, N., Khuraijam, S., Barman, D., Pandya, S. J., Majumdar, G., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.3910 · Cited by 20

Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39 countries and territories

Allemani, C., Minicozzi, P., Morawski, B. M., Lima, C. A., Bennett, D., Pongnikorn, D., Petrova, D., Innos, K., Girardi, F., Álvarez, Y. G., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01383-2 · Cited by 21

Breast cancer survival in Mexico between 2007 and 2016 in women without social security: a retrospective cohort study

Unger‐Saldaña, K., Bandala-Jacques, A., Huerta-Gutiérrez, R., Zamora-Muñoz, S., Hernández‐Ávila, J. E., Cabrera‐Galeana, P., Mohar, A., & Lajous, M. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100541 · Cited by 20

Multiplexing Determination of Cancer-Associated Biomarkers by Surface-Enhanced Raman Scattering Using Ordered Gold Nanohoneycomb Arrays

Li, L., Liu, C., Cao, X., Tan, L., & Lu, W. (2017) · Bioanalysis · doi:10.4155/bio-2016-0237 · Cited by 19

Targeted inhibition of WRN helicase, replication stress and cancer

Orlovetskie, N., Serruya, R., Abboud-Jarrous, G., & Jarrous, N. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.11.004 · Cited by 18

Survival trends for primary liver cancer, 1995–2009: analysis of individual data for 578,740 patients from 187 population-based registries in 36 countries (CONCORD-2)

CONCORD Working Group, Bannon, F. J., Carlo, V. D., Harewood, R., Engholm, G., Ferretti, S., Johnson, C. J., Aitken, J. F., Marcos‐Gragera, R., Bonaventure, A., et al. (2019) · Annals of Cancer Epidemiology · doi:10.21037/ace.2019.07.01 · Cited by 18

Survival analysis of colorectal cancer patients in a Thai hospital-based cancer registry

Kittrongsiri, K., Wanitsuwan, W., Prechawittayakul, P., Sangroongruangsri, S., Cairns, J., & Chaikledkaew, U. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1740087 · Cited by 19

Population‐based cancer staging for oesophageal, gastric, and pancreatic cancer 2012‐2014: International Cancer Benchmarking Partnership SurvMark ‐2

Cabasag, C. J., Arnold, M., Piñeros, M., Morgan, E., Brierley, J. D., Hofferkamp, J., Kehoe, S. T., Butler, J., Bucher, O., Bray, F., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33679 · Cited by 18

Prognostic significance of STIP1 expression in human cancer: A meta-analysis

Zhang, S., Shao, J., & Su, F. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.07.037 · Cited by 18

Cancer Survival Trends in Southeastern China, 2011–2021: A Population-Based Study

Zhou, Y., Wen, Y., Xiang, Z., Ma, J., Lin, Y., Huang, Y., & Chen, C. (2024) · Clinical Epidemiology · doi:10.2147/clep.s442152 · Cited by 17

Chemotherapy Related Cardiotoxicity Evaluation—A Contemporary Review with a Focus on Cardiac Imaging

Scalia, I. G., Gheyath, B., Tamarappoo, B. K., Moudgil, R., Otton, J. M., Pereyra, M., Narayanasamy, H., Larsen, C., Herrmann, J., Arsanjani, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133714 · Cited by 19

Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting CD24/CTNNB1/SOX4-Centered Signaling Hub

Shih, J.-W., Wu, A. T. H., Mokgautsi, N., Wei, P., & Huang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010609 · Cited by 15

RUFY3 promotes the progression of hepatocellular carcinoma through activating NF-κB-mediated epithelial-mesenchymal transition

Zhang, Y., Ni, W., & Qin, L. (2021) · Aging · doi:10.18632/aging.203444 · Cited by 15

Trends over 48 years in a one-number index of survival for all cancers combined, England and Wales (1971–2018): a population-based registry study

Coleman, M. P., Matz, M., Minicozzi, P., Carlo, V. D., Huws, D., Smits, S., Shelton, J., & Allemani, C. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2025.101385 · Cited by 15

Epidemiological trends of early-onset gastrointestinal cancers from 1990 to 2021 and predictions for 2036: analysis from the global burden of disease study 2021

Gong, Y.-Q., Lu, C.-J., Xiao, Y.-R., Zhang, J., Xu, Z., Li, J., & Huang, W.-F. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2555518 · Cited by 14

Cancer: the elephant in the room

Coleman, M. P., & Allemani, C. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60571-2 · Cited by 14

Trends in cancer survival by ethnic and socioeconomic group, New Zealand, 1991-2004

Soeberg, M. (2014) · Otago University Research Archive (University of Otago) · Cited by 14

Exposure to household tobacco smoke and risk of cancer morbidity and mortality: Analysis of data from the Afghanistan Demographic and Health Survey 2015

Bhatta, D. N., Hiatt, R. A., Loon, K. V., & Glantz, S. A. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.03.044 · Cited by 13

A Unifying Framework for Flexible Excess Hazard Modelling with Applications in Cancer Epidemiology

Eletti, A., Marra, G., Quaresma, M., Radice, R., & Rubio, F. J. (2022) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/rssc.12566 · Cited by 13

Transition of a Clinical Practice to Use of Subdural Drains after Burr Hole Evacuation of Chronic Subdural Hematoma: The Helsinki Experience

Tommiska, P., Lönnrot, K., Raj, R., Luostarinen, T., & Kivisaari, R. P. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.05.230 · Cited by 13

Palliative care guidelines for the management of HIV-infected people in South Africa

Spencer, D. C., Krause, R., Rossouw, T. M., Moosa, M. S., Browde, S., Maramba, E., Jankelowitz, L., Mulaudzi, M. B., Ratshikana-Moloko, M., Modupe, O. F., et al. (2019) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v20i1.1013 · Cited by 13

Practical considerations for expediting breast cancer treatment in Brazil

Bretas, G. D. O., Renna, N. L., & Bines, J. (2021) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100028 · Cited by 12

Population-based cancer survival in the Golestan province in the northeastern part of Iran 2007–2012

Nemati, S., Saeedi, E., Roshandel, G., Nahvijou, A., Badakhshan, A., Akbari, M., Sedaghat, S. M., Hasanpour‐Heidari, S., Hosseinpour, R., Salamat, F., et al. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2021.102089 · Cited by 12

Association of myocardial injury with adverse long-term survival among cancer patients

Bashar, H., Kobo, O. M., Curzen, N. P., & Mamas, M. A. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae116 · Cited by 12

Current Status of Malignant Neuropathic Pain in Chinese Patients with Cancer: Report of a Hospital‐based Investigation of Prevalence, Etiology, Assessment, and Treatment

Lü, F., Song, L., Xie, T., Tian, J., Fan, Y., & Liu, H. (2016) · Pain Practice · doi:10.1111/papr.12422 · Cited by 12

Patterns of age-specific socioeconomic inequalities in net survival for common cancers in Taiwan, a country with universal health coverage

Chien, L.-H., Tseng, T., Tsai, F., Wang, J.-H., Hsiung, C. A., Liu, T., & Chang, I. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.01.006 · Cited by 11

LncRNA‐EWSAT1 promotes hepatocellular carcinoma metastasis via activation of the Src‐YAP signaling axis

He, X., Chen, J., Zhou, J., Mao, A., Xu, W., Zhu, H., Pan, Q., Zhao, Y., Zhang, N., Wang, L., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200825r · Cited by 10

Achieving better cancer intelligence for global cancer control

Sullivan, R. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30155-7 · Cited by 9

Calpain Small Subunit 1 Protein in the Prognosis of Cancer Survivors and Its Clinicopathological Correlation

Tang, S., Yin, Q., Liu, F., & Zhang, Y. (2019) · BioMed Research International · doi:10.1155/2019/8053706 · Cited by 9

Global Trends in Survival From Astrocytic Tumors in Adolescents and Young Adults: A Systematic Review

Girardi, F., Allemani, C., & Coleman, M. P. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa049 · Cited by 9

Genetic Background in Patients with Cancer Therapy-Induced Cardiomyopathy

Fazzini, L., Campana, N., Cossu, S., Deidda, M., Madaudo, C., Quagliariello, V., Maurea, N., Lisi, D. D., Novo, G., Zito, C., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041286 · Cited by 8

Web-based remote psychological intervention improves cancer treatment

Wang, P., Yu, T., & Yang, L. (2016) · Psychology Health & Medicine · doi:10.1080/13548506.2016.1247212 · Cited by 8

A novel approach based on magneto-electric torque sensor for non-contact biomarkers detection

Wu, Y., Liu, Y., Li, F., Zhou, Y., Ding, J., & Li, R. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.08.083 · Cited by 8

Study on the targeted therapy of oral squamous cell carcinoma with a plasmid expressing PE38KDEL toxin under control of the SERPINB3 promoter

Wu, J., Guo, Q., Zhang, G., Zhao, L., Lv, Y., Wang, J., Liu, J., & Shi, W. (2020) · Cancer Medicine · doi:10.1002/cam4.2880 · Cited by 8

Required Data Elements and Requirements of a Teleoncology System to Provide Treatment Plans for Patients with Breast Cancer

Khodaveisi, T., Sadoughi, F., & Novin, K. (2020) · International Journal of Cancer Management · doi:10.5812/ijcm.100522 · Cited by 8

BLZF1 expression is of prognostic significance in hepatocellular carcinoma

Huang, R., Su, S., Wu, D.-C., Fu, J., & Zeng, X. Z. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.119 · Cited by 8

Racial-Sex Disparities—A Challenging Battle Against Cancer Mortality in the USA

Fu, W. J. (2014) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-014-0059-6 · Cited by 8

Impact of Funding Source on Long-Term Outcomes in Prostate Cancer: Analysis of a Large Public Database From Sao Paulo, Brazil

Maluf, F. C., de Oliveira, C. K. L. S., & Ziegelmann, P. K. (2025) · JCO Global Oncology · doi:10.1200/go-24-00271 · Cited by 7

Immunohistochemical Expression Pattern of MLH1, MSH2, MSH6, and PMS2 in Tumor Specimen of Iranian Gastric Carcinoma Patients

Salari, S., Ghadyani, M., Karimi, M., Mortezazadeh, M., & Vahedifard, F. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00566-x · Cited by 7

Survival in stomach cancer: analysis of a national cancer information system and a population-based cancer registry in Colombia

Bravo, L. E., Vargas, J. A. H., Collazos, P. A., García, L. S., Valbuena‐Garcia, A. M., & Acuña, L. (2022) · Colombia medica · doi:10.25100/cm.v53i4.5126 · Cited by 7

Cancer survival

OECD, & Bank, T. W. (2020) · Health at a Glance: Latin America and the Caribbean 2020 · doi:10.1787/bf64007e-en

Sobrevivencia del cáncer

OECD, & Bank, T. W. (2020) · OECD eBooks · doi:10.1787/3f8e6600-es

Cancer survival: global variation and long-term trends

Lyratzopoulos, G. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.36 · Cited by 5

Achieving better cancer intelligence for global cancer control

Sullivan, R. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30155-7 · Cited by 9

Think globally about cancer

(2019) · Nature Medicine · doi:10.1038/s41591-019-0402-x · Cited by 8